Kornitzer Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Kornitzer Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-71,770	Closed	-$3.38M	–	525
2022 Q3	$3.38M	Hold	71,770	–	–	0.07%	271
2022 Q2	$5.14M	Sell	71,770 -51,485	-42%	-$3.76M	0.1%	245
2022 Q1	$9.98M	Sell	123,255 -92,480	-43%	-$7.82M	0.16%	201
2021 Q4	$22.2M	Sell	215,735 -100	-0%	-$9.6K	0.33%	94
2021 Q3	$18.9M	Sell	215,835 -25	-0%	-$2.26K	0.29%	123
2021 Q2	$19.3M	Sell	215,860 -25	-0%	-$2.11K	0.29%	129
2021 Q1	$16.4M	Buy	215,885 +12,715	+6%	+$959K	0.26%	143
2020 Q4	$13.8M	Buy	203,170 +57,335	+39%	+$3.57M	0.23%	156
2020 Q3	$7.75M	Buy	145,835 +64,030	+78%	+$3.81M	0.15%	205
2020 Q2	$4.76M	Sell	81,805 -34,445	-30%	-$1.85M	0.1%	256
2020 Q1	$4.58M	Buy	116,250 +16,320	+16%	+$954K	0.11%	236
2019 Q4	$5.94M	Sell	99,930 -36,665	-27%	-$1.97M	0.11%	243
2019 Q3	$7.27M	Sell	136,595 -15,240	-10%	-$782K	0.13%	210
2019 Q2	$7.76M	Sell	151,835 -42,695	-22%	-$1.99M	0.14%	200
2019 Q1	$10.1M	Sell	194,530 -88,585	-31%	-$4.29M	0.18%	162
2018 Q4	$11.1M	Sell	283,115 -12,008	-4%	-$558K	0.22%	139
2018 Q3	$15.2M	Buy	295,123 +11,465	+4%	+$561K	0.24%	136
2018 Q2	$13.3M	Buy	283,658 +32,008	+13%	+$1.32M	0.22%	137
2018 Q1	$8.93M	Sell	251,650 -10,390	-4%	-$407K	0.15%	187
2017 Q4	$11.4M	Buy	262,040 +76,040	+41%	+$3.55M	0.19%	157
2017 Q3	$9.73M	Buy	186,000 +47,225	+34%	+$2.63M	0.17%	179
2017 Q2	$8.12M	Sell	138,775 -32,945	-19%	-$1.71M	0.14%	202
2017 Q1	$7.87M	Buy	171,720 +210	+0.1%	+$10.4K	0.14%	208
2016 Q4	$9.02M	Sell	171,510 -69,615	-29%	-$3.37M	0.17%	191
2016 Q3	$10.7M	Sell	241,125 -995	-0.4%	-$43.2K	0.19%	182
2016 Q2	$9.23M	Buy	242,120 +178,835	+283%	+$7.86M	0.17%	192
2016 Q1	$2.61M	Buy	+63,285	New	+$2.61M	0.04%	285

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kornitzer Capital Management's SYNH Position: Q4 2022 in Review

Kornitzer Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 71,770 shares — an estimated $3.38M sold.

Kornitzer Capital Management first reported a position in SYNH in Q1 2016 and held it in 27 quarters. The position peaked at $22.2M in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Kornitzer Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Kornitzer Capital Management sold 71,770 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $3.38M.
Kornitzer Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 27 quarters.
Kornitzer Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $22.2M in Q4 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.